Bausch & Lomb Incorporated
Rochester, New York, 14609, United States
NCT Number: NCT01309100
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lens.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14609, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bausch & Lomb investigational silicone hydrogel lens on a daily wear basis for 1 week.
Johnson & Johnson Acuvue Oasys contact lens on a daily wear basis for 1 week.
Ciba Vision Air Optix Aqua contact lens on a daily wear basis for 1 week.
Time frame: 1 week
The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.
Time frame: 1 week
The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.
Time frame: 1 week
The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.
Time frame: 1 week
The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.
Bausch & Lomb Incorporated
Industry
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details